LSL Videos
BIOPHARMA AND THE MANAGEMENT OF WALL ST. DURING A PANDEMIC
-
![rob-roundtable-banner]( "Biopharma And The Management Of Wall St. During A Pandemic")
Biopharma And The Management Of Wall St. During A PandemicThe volatility of the U.S. stock market in the first half of 2020 has even the heartiest investor queasy. But how about the leaders of such publicly traded companies? We conduct a virtual roundtable with three CEOs of publicly traded biopharmaceutical companies to learn how they are leading their organizations while also managing the expectations of Wall Street during the COVID-19 pandemic.
- Taking On Debt And Executing A Public Offering During COVID-19
- Why Chimerix Pivoted To Take On COVID-19
- Managing Clinical Trials And Supply Amidst COVID-19 Outbreak
- Serving Traumatic Injury Patients And Surgeons During Pandemic Panic
- Biopharma CEOs Weigh In On Working With Wall St. During Pandemic Pandemonium
- AxoGen CEO Details Approach To Crisis Management During COVID-19
- Don’t Let Efforts To Solve COVID-19 Capsize Decades Of Drug Development Work
- Navigating The Delivery Of Data Via Virtual Conferences And Meetings
LEADERSHIP DURING COVID-19 — A BIOPHARMA CEO ROUNDTABLE
-
![COVID 19 Coronavirus]( "Leadership During COVID-19 — A Biopharma CEO Roundtable")
Leadership During COVID-19 — A Biopharma CEO RoundtableFive biopharmaceutical industry CEOs discuss challenges their company's have faced, along with best practices implemented in managing through the COVID-19 chaos.
VIRTUAL ROUNDTABLES
During the COVID-19 pandemic of 2020, Life Science Leader decided to engage with some of our executive-level readers via Zoom conference calls. These virtual roundtables were hosted by our Chief Editor Rob Wright and then broken up into shorter clips based on specific questions or topics discussed during the full-length call.